Darby S C, Olsen J H, Doll R, Thakrar B, Brown P D, Storm H H, Barlow L, Langmark F, Teppo L, Tulinius H
Imperial Cancer Research Fund Cancer Epidemiology Unit, University of Oxford, Radcliffe Infirmary, United Kingdom.
BMJ. 1992 Apr 18;304(6833):1005-9. doi: 10.1136/bmj.304.6833.1005.
To obtain further information about the risks of childhood leukaemia after exposure to ionising radiation at low doses and low dose rates before or after birth or to the father's testes shortly before conception.
Observational study of trends in incidence of childhood leukaemia in relation to estimated radiation exposures due to fallout from atmospheric nuclear weapons testing during the 1950s and 1960s.
Nordic countries.
Children aged under 15 years.
Incidence rates of leukaemia by age at diagnosis, sex, country, and calendar year of diagnosis or year of birth; exposure category; relation between leukaemia and exposure for children aged 0-14 and 0-4 separately.
During the high fallout period the average estimated dose equivalent to the fetal red bone marrow was around 140 mu Sv and the average annual testicular dose 140 mu Sv. There was little evidence of increased incidence of leukaemia among children born in these years. Doses to the red bone marrow of a child after birth were higher, and during the high exposure period children would have been subjected to an additional dose equivalent of around 1500 mu Sv, similar to doses received by children in several parts of central and eastern Europe owing to the Chernobyl accident and about 50% greater than the annual dose equivalent to the red bone marrow of a child from natural radiation. leukaemia incidence and red marrow dose was not related overall, but rates of leukaemia in the high exposure period were slightly higher than in the surrounding medium exposure period (relative risk for ages 0-14: 1.07, 95% confidence interval 1.00 to 1.14; for ages 0-4: 1.11, 1.00 to 1.24).
Current predicted risks of childhood leukaemia after exposure to radiation are not greatly underestimated for low dose rate exposures.
获取更多关于儿童在出生前或出生后暴露于低剂量和低剂量率电离辐射,或在受孕前不久父亲睾丸暴露于电离辐射后患白血病风险的信息。
一项观察性研究,研究20世纪50年代和60年代大气核武器试验沉降物所致估计辐射暴露与儿童白血病发病率趋势之间的关系。
北欧国家。
15岁以下儿童。
按诊断时年龄、性别、国家以及诊断年份或出生年份划分的白血病发病率;暴露类别;分别针对0 - 14岁和0 - 4岁儿童,白血病与暴露之间的关系。
在高沉降期,估计胎儿红骨髓平均等效剂量约为140微希沃特,睾丸年均剂量为140微希沃特。这些年份出生的儿童中几乎没有白血病发病率增加的证据。儿童出生后红骨髓所受剂量更高,在高暴露期儿童额外受到的等效剂量约为1500微希沃特,这与中欧和东欧部分地区儿童因切尔诺贝利事故所受剂量相似,比儿童因天然辐射每年红骨髓等效剂量约高50%。白血病发病率与红骨髓剂量总体上无关联,但高暴露期的白血病发病率略高于周围的中等暴露期(0 - 14岁儿童的相对风险:1.07,95%置信区间1.00至1.14;0 - 4岁儿童:1.11,1.00至1.24)。
对于低剂量率辐射暴露,目前预测的儿童暴露于辐射后患白血病的风险并未被严重低估。